The prospects for immunotherapy in smoking cessation.
Hall
Wayne
W
Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, UK. w.hall@imb.uq.edu.au
D000293:Adolescent; D000328:Adult; D000906:Antibodies / Q000627:therapeutic use*; D001812:Blood-Brain Barrier; D004195:Disease Models, Animal; D006266:Health Education; D006801:Humans; D020380:Needs Assessment; D009538:Nicotine / Q000276:immunology* / Q000493:pharmacokinetics; D010349:Patient Compliance / Q000523:psychology; D012008:Recurrence; D012907:Smoking / Q000276:immunology* / Q000523:psychology; D016540:Smoking Cessation / Q000379:methods* / Q000523:psychology; D000074606:Smoking Prevention; D016896:Treatment Outcome; D014611:Vaccination / Q000379:methods* / Q000523:psychology / Q000639:trends
D000906:Antibodies; D009538:Nicotine